Jeannick Cizeau
Plus aucun poste en cours
Profil
Jeannick Cizeau formerly worked at Sesen Bio, Inc., as Head of Research.
Dr. Cizeau received his graduate degree from the University of Orléans.
Anciens postes connus de Jeannick Cizeau
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Jeannick Cizeau
| University of Orléans | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
